Day-one generic pricing is rarely at the floor
PBM Decisions Should Prioritize Clinical Evidence, Not Just Bottom Lines : While we understand the need for cost management, formulary decisions for chronic, complex diseases like obesity must be driven by clinical evidence, patient outcomes, and provider expertise
How PlexusDx Supports a More Personalized Approach PlexusDx genetic testing reveals predispositions in MC4R, and FTO pathways that may help provide context for how aggressively your appetite hormones rebound and how quickly your metabolic rate adapts after discontinuation
Millions of capsules were sold globally
This in turn leads to excessive storage of underutilized glucose in the liver (glycogenesis), the potential for developing fatty liver (ie, nonalcoholic steatohepatitis), and conversion of excess carbohydrates to fatty acids and triglycerides, with subsequent storage in adipose tissue